Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FormerXBC Inc XEBEQ

Xebec Adsorption Inc designs, engineers, and manufactures products that are used for purification, separation, dehydration, and filtration equipment for gases and compressed air. The company operates in three reportable segments: Systems, Corporate and other, and Support. Its product lines are natural gas dryers for natural gas refueling stations, compressed gas filtration, biogas purification, associated gas, engineering services, and air dryers. The company's geographical segments are United States, Canada, China, Other, Korea, Italy, and France.


GREY:XEBEQ - Post by User

Post by retiredcfon Dec 21, 2021 9:32am
283 Views
Post# 34249923

Year End Summary

Year End Summary

Over the past year, shares of XBC have seen significant negative momentum on the back of inconsistent margins, and negative impacts of the legacy contract. A buy case can indeed be made here, especially from such lower valuations as before. The sector outlook is strong, and given the negative sentiment, new contracts would likely help. Additionally, if margins do improve, investors will afford it at a higher valuation. The balance sheet remains strong, but margin improvement may take longer than expected. There are better names to own, but valuation vs potential profile is noteworthy here. Trading at 2.0x forward sales, sales are expected to grow at a CAGR of 20.5% over the next five years, and earnings are expected to turn positive in 2023. Over the next few quarters, we need to see improvement in sales, cash flow, margins, and general execution. This should be matched with an improvement in stock momentum for us to get excited again.

Provided by 5iResearch.  GLTA


<< Previous
Bullboard Posts
Next >>